Fate Short Long Term Debt Total from 2010 to 2024

FATE Stock  USD 4.09  0.14  3.54%   
Fate Therapeutics' Short and Long Term Debt Total is increasing over the years with slightly volatile fluctuation. Overall, Short and Long Term Debt Total is expected to go to about 108.7 M this year. During the period from 2010 to 2024 Fate Therapeutics Short and Long Term Debt Total annual values regression line had geometric mean of  20,472,342 and mean square error of 568.3 T. View All Fundamentals
 
Short and Long Term Debt Total  
First Reported
2012-12-31
Previous Quarter
105 M
Current Value
103.5 M
Quarterly Volatility
43.9 M
 
Yuan Drop
 
Covid
Check Fate Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Fate main balance sheet or income statement drivers, such as Depreciation And Amortization of 19.2 M, Interest Expense of 7.1 M or Selling General Administrative of 85.5 M, as well as many exotic indicators such as Price To Sales Ratio of 5.5, Dividend Yield of 0.06 or PTB Ratio of 0.95. Fate financial statements analysis is a perfect complement when working with Fate Therapeutics Valuation or Volatility modules.
  
This module can also supplement Fate Therapeutics' financial leverage analysis and stock options assessment as well as various Fate Therapeutics Technical models . Check out the analysis of Fate Therapeutics Correlation against competitors.
For information on how to trade Fate Stock refer to our How to Trade Fate Stock guide.

Latest Fate Therapeutics' Short Long Term Debt Total Growth Pattern

Below is the plot of the Short Long Term Debt Total of Fate Therapeutics over the last few years. It is Fate Therapeutics' Short and Long Term Debt Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Fate Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Short Long Term Debt Total10 Years Trend
Slightly volatile
   Short Long Term Debt Total   
       Timeline  

Fate Short Long Term Debt Total Regression Statistics

Arithmetic Mean43,597,320
Geometric Mean20,472,342
Coefficient Of Variation107.40
Mean Deviation42,095,493
Median18,238,000
Standard Deviation46,822,999
Sample Variance2192.4T
Range113.1M
R-Value0.87
Mean Square Error568.3T
R-Squared0.76
Significance0.000023
Slope9,123,388
Total Sum of Squares30693.5T

Fate Short Long Term Debt Total History

2024108.7 M
2023103.5 M
2022109.3 M
2021114.8 M
202097.3 M
201926.9 M
201814.9 M

About Fate Therapeutics Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Fate Therapeutics income statement, its balance sheet, and the statement of cash flows. Fate Therapeutics investors use historical funamental indicators, such as Fate Therapeutics's Short Long Term Debt Total, to determine how well the company is positioned to perform in the future. Although Fate Therapeutics investors may use each financial statement separately, they are all related. The changes in Fate Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Fate Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Fate Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Fate Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Short and Long Term Debt Total103.5 M108.7 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Fate Therapeutics is a strong investment it is important to analyze Fate Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Fate Therapeutics' future performance. For an informed investment choice regarding Fate Stock, refer to the following important reports:
Check out the analysis of Fate Therapeutics Correlation against competitors.
For information on how to trade Fate Stock refer to our How to Trade Fate Stock guide.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Complementary Tools for Fate Stock analysis

When running Fate Therapeutics' price analysis, check to measure Fate Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fate Therapeutics is operating at the current time. Most of Fate Therapeutics' value examination focuses on studying past and present price action to predict the probability of Fate Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fate Therapeutics' price. Additionally, you may evaluate how the addition of Fate Therapeutics to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Is Fate Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fate Therapeutics. If investors know Fate will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fate Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.64)
Revenue Per Share
0.646
Quarterly Revenue Growth
(0.96)
Return On Assets
(0.18)
Return On Equity
(0.38)
The market value of Fate Therapeutics is measured differently than its book value, which is the value of Fate that is recorded on the company's balance sheet. Investors also form their own opinion of Fate Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Fate Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fate Therapeutics' market value can be influenced by many factors that don't directly affect Fate Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fate Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fate Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fate Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.